Ozempic and Wegovy maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

Sen. Bernie Sanders grilled Novo Nordisk CEO Lars Jorgensen during a Tuesday Senate hearing regarding the cost of its weight-loss drugs in the U.S. In opening remarks before the Senate Health ...